SCHEMBL3733529

SCHEMBL3733529

Cc1cc(N)ccc1-c1cccc(OC(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 2/20 0.46
ADORA2A P29274 1/20 0.46
XDH P47989 2/20 0.44
KCNH2 Q12809 1/20 0.43
SCN10A Q9Y5Y9 1/20 0.43
MMP2 P08253 1/20 0.43
MMP3 P08254 1/20 0.43
SCN5A Q14524 1/20 0.41
MGLL Q99685 1/20 0.40
PIM1 P11309 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
DYRK1A Q13627 2/20 0.39
PRMT1 Q99873 1/20 0.39
GPR3 P46089 2/20 0.39
PTGES2 Q9H7Z7 1/20 0.39
POLQ O75417 1/20 0.39
GALR1 P47211 1/20 0.39
DHODH Q02127 1/20 0.38
CTSD P07339 1/20 0.38
BACE1 P56817 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1242930 0.83 SCN5A (0.46) KCNH2SCN10ASCN5AGPR3
SCHEMBL7113080 0.81 CYP3A4 (0.56) ADORA1ADORA2AKCNH2DYRK1ABACE1
SCHEMBL5542629 0.81 ADORA2A (0.47) ADORA1ADORA2AXDHKCNH2SCN10A
SCHEMBL21770721 0.81 ADORA1 (0.47) ADORA1ADORA2AXDHKCNH2SCN10A
SCHEMBL3728446 0.80 SCN9A (0.46) ADORA1ADORA2AXDHKCNH2SCN10A
SCHEMBL21770724 0.79 ADORA1 (0.46) ADORA1ADORA2AXDHKCNH2SCN10A
SCHEMBL21770975 0.79 XDH (0.51) ADORA1ADORA2AXDHKCNH2SCN10A
SCHEMBL1337217 0.78 TAAR1 (0.52) ADORA1ADORA2AXDHKCNH2SCN10A
SCHEMBL3786056 0.77 MAOA (0.50)
SCHEMBL2749090 0.77 MAPT (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8691852-B2 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors AMIRALL, S.A. (ES) 2014-04-08 US disclosed
US-20120294854-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. 2012-11-22 US disclosed
US-8258308-B2 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors LABORATORIOS ALMIRALL, S.A. (ES) 2012-09-04 US disclosed
EP-2121614-B1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS ALMIRALL SA (ES) 2012-06-20 EP disclosed
US-20100074898-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. (ES) 2010-03-25 US disclosed
EP-2121614-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS Almirall, S.A. (ES) 2009-11-25 EP disclosed
WO-2008077639-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS LABORATORIOS ALMIRALL, S.A. (ES) 2008-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100074898-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS DHODH, NQO2, DAO ADORA1 391/4885ADORA2A 547/4885XDH 20/4885
US-20120294854-A1 AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS DHODH, NQO2, DAO ADORA1 391/4885ADORA2A 547/4885XDH 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.